Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Erratum.
Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis.
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.
Uses of complementary and alternative medicine in multiple sclerosis.
"Disease modifying nutricals" for multiple sclerosis.
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Vitamin D and multiple sclerosis: what is the clinical impact?
PML risk stratification using anti-JCV antibody index and L-selectin.
The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease. By Douglas McAlpine. From the Institute of Clinical Research, The Middlesex Hospital Medical Sc
Segmentation of Multiple Sclerosis Lesions in Brain MR Images Using Spatially Constrained Possibilistic Fuzzy C-Means Classification.
Differential effect of baclofen on cortical and spinal inhibitory circuits.
Comparative validity of accelerometer based measures of physical activity for people with multiple sclerosis.
Pharmacodynamic models for discrete data.
Association Between Glutamate Blockade and Fatigue in Patients With Multiple Sclerosis.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Opexa Therapeutics Announces Tcelna™ as New Brand Name for MS Therapy
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Genetic targeting of microglia.
FTY720 (Fingolimod) attenuates basal and sphingosine 1-phosphate-evoked thyroid cancer cell invasion.
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
Application of the fuzzy logic concept in the multiple sclerosis functional composite for scoring the progress of multiple sclerosis.
Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.
[Processing speed in relapsing-remitting multiple sclerosis: the role played by the depressive symptoms].
Pages
« first
‹ previous
…
214
215
216
217
218
219
220
221
222
…
next ›
last »